Skip to Content
Merck
  • N,N,N-trimethylsphingosine modifies aggregatory response and ATP release from platelets in whole blood.

N,N,N-trimethylsphingosine modifies aggregatory response and ATP release from platelets in whole blood.

Thrombosis research (1994-11-15)
R Knöfler, T Urano, Y Takada, A Takada
ABSTRACT

We investigated the influence of N,N,N-trimethylsphingosine (TMS), a potent inhibitor of protein kinase C (PKC), on whole blood aggregation and ATP release from platelets. The preincubation with TMS at 1 microM for 2 min enhanced ATP release during arachidonic acid-induced aggregation. The ristocetin-induced agglutination was inhibited in a TMS concentration-dependent manner, which suggests that TMS may interact with the vWF receptor on platelets. TMS suppressed aggregatory response and ATP release from platelets after the addition of collagen. In contrast, the platelet aggregation induced by ADP and 12-O-tetradecanoylphorbol-13-acetate (TPA) was only slightly inhibited and the ATP release was not influenced after preincubation with TMS. Our results are in contrast to previous reported data, which were obtained using PRP and washed platelets.

MATERIALS
Product Number
Brand
Product Description

Avanti
Trimethyl Sphingosine (d18:1), Avanti Research - A Croda Brand 860497P, powder